Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scopis was a Germany-based medical technology company that developed and commercialized image-guided surgical navigation systems for minimally invasive procedures. Its products combined optical and electromagnetic tracking, augmented reality visualization, and surgical planning software for ENT, craniomaxillofacial, neuro, spine, and bronchoscopic applications. The company emerged as a spin-out from Charité – Universitätsmedizin Berlin and Fraunhofer IPK and built a differentiated platform around endoscopic and microscopic navigation. Scopis also developed mixed-reality and holographic navigation capabilities, including integrations with Microsoft HoloLens. The company was acquired by Stryker in 2017, and its technology continues to be reflected in Stryker ENT navigation offerings powered by Scopis software.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scopis.